Profusa Inc (PFSA) Stock Price, Quote & News

Company Profile

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berk...

Industry: Medical Devices

Sector: Healthcare

Phone: 925 997 6925

Website: profusa.com

Address:

626 Bancroft Way, Suite A, Berkeley, United States

jeni1988 Jun. 12 at 5:26 PM

$PFSA Everyday new ATL🤮🤮🤮🤮🤮🤡🤡🤡

0 · Reply

ShadowSnake Jun. 12 at 1:46 PM

$PFSA pos

0 · Reply

ka1954 Jun. 12 at 1:35 PM

$PFSA piece of crap

0 · Reply

TA_Kongen Jun. 12 at 12:10 PM

$PFSA 200 million shares to dump at 97% lowest VWAP last trading days. If price drops after they issued shares they will have to issue more. One of the worst death spirals I have ever seen here. It is a miracle if this gets a pump. Will get adjusted to R/S as well.

1 · Reply

Hidenbidencornpop Jun. 12 at 12:42 AM

$PFSA primed to run

0 · Reply

Nuclear_Elvis Jun. 11 at 1:11 AM

$PFSA Price is right back to where it was before the last Reverse Split. CEO should be ashamed to simply walk down the hallway at the company.

0 · Reply

jeni1988 Jun. 10 at 7:41 PM

$PFSA Welcome ATL mdfckers🤡🤡🤡🤡🤡

0 · Reply

jeni1988 Jun. 10 at 7:17 PM

$PFSA 🤮🤮🤮🤮🤮🤡🤡🤡🤡

0 · Reply

dln101 Jun. 9 at 8:06 PM

$PFSA looks like theres a big gap to fill for this loaded penny 🤔 $DSS $PAVS $ELPW style 💪📈

0 · Reply

ericus20 Jun. 8 at 11:28 PM

$PFSA $RDAC primed and ready to go!!!!!

0 · Reply

Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform

Jun 10, 2026, 8:00 AM EDT - 3 days ago

Profusa Issues Letter to Shareholders Encouraging Shareholders to Vote FOR All Proposals at June 23, 2026 Annual Meeting

2026-05-15T14:05:41.000Z - 4 weeks ago

Profusa to transfer listing to Nasdaq

May 15, 2026, 7:30 AM EDT - 4 weeks ago

Profusa Announces Listing Transfer to The Nasdaq Capital Market

2026-05-08T10:07:48.000Z - 5 weeks ago

Profusa receives favorable Nasdaq listing determination

May 8, 2026, 6:00 AM EDT - 5 weeks ago

Profusa Receives Favorable Nasdaq Listing Determination

May 5, 2026, 8:30 AM EDT - 5 weeks ago

Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value

2026-04-06T10:05:05.000Z - 2 months ago

Profusa announces $30M letter of intent for PanOmics diagnostic platform

Apr 6, 2026, 6:00 AM EDT - 2 months ago

Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform

Feb 27, 2026, 9:15 AM EST - 3 months ago

Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering

Feb 19, 2026, 8:30 AM EST - 4 months ago

Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance

Feb 13, 2026, 8:30 AM EST - 4 months ago

Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies

Feb 5, 2026, 8:00 AM EST - 4 months ago

Profusa Announces 1-for-75 Reverse Stock Split

Jan 29, 2026, 8:00 AM EST - 4 months ago

Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026

Jan 16, 2026, 7:30 AM EST - 5 months ago

Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue

Jan 8, 2026, 7:30 AM EST - 5 months ago

Profusa Adds Leading Greek Vascular Surgeon to Customer Base

Dec 31, 2025, 7:30 AM EST - 5 months ago

Profusa Bolsters European Commercial Network with New French Distributor, MedSell

2025-12-30T14:56:15.000Z - 5 months ago

Here’s Why Profusa Stock (PFSA) Rocketed Today

Dec 30, 2025, 7:30 AM EST - 5 months ago

Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35

Dec 15, 2025, 7:30 AM EST - 6 months ago

Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025

Dec 11, 2025, 8:30 AM EST - 6 months ago

Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026

Nov 24, 2025, 8:15 AM EST - 7 months ago

Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025

Nov 19, 2025, 5:44 PM EST - 7 months ago

Profusa Announces Third Quarter Business and Financial Highlights

Oct 30, 2025, 7:30 AM EDT - 8 months ago

Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches

Oct 28, 2025, 8:30 AM EDT - 8 months ago

Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026

Oct 22, 2025, 8:30 AM EDT - 8 months ago

Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe

Oct 7, 2025, 8:15 AM EDT - 8 months ago

Profusa Invests Additional $1 Million in Digital Treasury Assets

Oct 1, 2025, 8:30 AM EDT - 9 months ago

Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base

Sep 11, 2025, 8:30 AM EDT - 9 months ago

Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring

Sep 4, 2025, 8:30 AM EDT - 10 months ago

Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base

Aug 27, 2025, 8:45 AM EDT - 10 months ago

Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria

Aug 19, 2025, 8:15 AM EDT - 10 months ago

Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O'Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO

Aug 6, 2025, 8:15 AM EDT - 11 months ago

Profusa, Inc. Provides Strategy Overview and Business Update for Investors

Jul 31, 2025, 8:15 AM EDT - 11 months ago

Profusa Secures Lumee™ Oxygen Platform Distributor in Spain

Jul 21, 2025, 8:00 AM EDT - 11 months ago

Profusa Announces $100 Million Equity Line of Credit to Initiate Bitcoin Treasury Strategy

Jul 11, 2025, 4:00 PM EDT - 1 year ago

Profusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq

jeni1988 Jun. 12 at 5:26 PM

$PFSA Everyday new ATL🤮🤮🤮🤮🤮🤡🤡🤡

0 · Reply

ShadowSnake Jun. 12 at 1:46 PM

$PFSA pos

0 · Reply

ka1954 Jun. 12 at 1:35 PM

$PFSA piece of crap

0 · Reply

TA_Kongen Jun. 12 at 12:10 PM

1 · Reply

Hidenbidencornpop Jun. 12 at 12:42 AM

$PFSA primed to run

0 · Reply

Nuclear_Elvis Jun. 11 at 1:11 AM

$PFSA Price is right back to where it was before the last Reverse Split. CEO should be ashamed to simply walk down the hallway at the company.

0 · Reply

jeni1988 Jun. 10 at 7:41 PM

$PFSA Welcome ATL mdfckers🤡🤡🤡🤡🤡

0 · Reply

jeni1988 Jun. 10 at 7:17 PM

$PFSA 🤮🤮🤮🤮🤮🤡🤡🤡🤡

0 · Reply

dln101 Jun. 9 at 8:06 PM

$PFSA looks like theres a big gap to fill for this loaded penny 🤔 $DSS $PAVS $ELPW style 💪📈

0 · Reply

ericus20 Jun. 8 at 11:28 PM

$PFSA $RDAC primed and ready to go!!!!!

0 · Reply

alby777 Jun. 3 at 4:45 PM

$PFSA M&A!?

0 · Reply

alby777 Jun. 3 at 2:08 PM

$PFSA Abbott Labs Buys PFSA!? Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.... M&A!?

0 · Reply

alby777 Jun. 3 at 1:59 PM

$PFSA M&A!? Potential Buyers, Senseonics Holdings, Autonomix Medical, Abbott Laboratories, and or Cambridge Medical Technologies. M&A!?

0 · Reply

NewNewOld Jun. 3 at 8:52 AM

$PFSA and mullen automotive i found new similar shit like you. $SOAR

0 · Reply

alby777 Jun. 2 at 8:29 PM

$PFSA M&A? Ascent Partners Fund LLC regularly buys PFSA (Profusa, Inc.) stock. Under an Equity Line of Credit (ELOC) and ongoing Securities Purchase Agreements (initially formed in July 2025 and amended multiple times), Profusa has been authorized to sell up to $\$100\text{ million}$ in common stock to Ascent.Recent transactions and updates include:May 2026: Profusa submitted an Advance Notice requesting that Ascent purchase up to $9.99\%$ of their outstanding shares per notice (capped at $\$300,000$ per transaction)

0 · Reply

alby777 Jun. 2 at 5:05 PM

$PFSA M&A? There are no active buyout offers or official proposals for PFSA. Rather than being acquired, the digital health company is focused on its own acquisitions and partnerships to scale its tissue-integrated biosensor technologies, such as its recent multi-omics platform integration and collaboration with the Mayo Clinic.

0 · Reply

alby777 Jun. 2 at 3:00 PM

$PFSA M&A!? Which giant Pharma co. will Buy PFSA!? https://investors.profusa.com/email-alerts

0 · Reply

alby777 Jun. 2 at 2:46 PM

$PFSA https://materials.proxyvote.com/Approved/74319X/20260512/FO10K_635862.PDF

0 · Reply

alby777 Jun. 2 at 2:45 PM

$PFSA PROFUSA, INC. June 23, 2026 Annual Meeting Vote Shares by June 22, 2026

0 · Reply

ShadowSnake Jun. 2 at 1:03 PM

$PFSA 1:200!? FU

1 · Reply

Hydrojim May. 29 at 3:09 AM

$PFSA

0 · Reply

focafoca99 May. 26 at 3:43 PM

$PFSA amended its asset purchase agreement, deleting the management‑share provision and issuing $30 M of Series A convertible preferred

0 · Reply

Market Cap	1.27M
Revenue (ttm)	0.00
Net Income (ttm)	-35.82M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	-0.17

Volume	1,031,900
Avg Vol	6,082,000
Day's Range	N/A - N/A
Shares Out	4.66M
Stochastic %K	6%
Beta	0.35
Analysts	Strong Buy
Price Target	N/A